Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 319

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 16B
Chunk 319
---
ITEM 16B. CODE OF
ETHICS

In July 2011, our board of directors adopted a Code of Business
Conduct and Ethics, or the Code of Conduct, that applies to all our employees, including without limitation our CEO, CFO and controller.
Our Code of Conduct may be viewed on our website at www. biolinerx. com.
The information contained on or through our website, or any other website referred to herein, is not incorporated by reference into this
Annual Report on Form 20-F. A copy of our Code of Conduct may be obtained, without charge, upon a written request addressed to our investor
relations department, 2 HaMa’ayan Street, Modi’in 7177871, Israel (Telephone no. +972-8-642-9100) (e-mail: info@BioLineRx. com).

106

ITEM 16C. PRINCIPAL
ACCOUNTANT FEES AND SERVICES